Findings suggest that identifying children with specific eating behaviors might be a promising approach for targeted intervention to prevent progression eating disorders in adolescence.
Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
Binge eating and purging were found to be common among adolescents and seen at a higher rate in female adolescents.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for dasotraline (Sunovion) in the treatment of binge eating disorder.
Individuals who tend to experience negative affect and diabetes distress before eating are at increased risk for objective binge eating at an upcoming meal.
Comparable clinical characteristics and responses to dose-optimized lisdexamfetamine dimesylate compared with placebo were seen in patients with binge eating disorder across age and sex.
Researchers compared the effects of long-acting methylphenidate and individual CBT for binge eating disorder in women.
Investigators examine extreme weight control behaviors in both adolescent boys and girls.
Investigators observed a link between food insecurity — difficulty affording enough food to support regular, balanced meals — and increased probability of binge-eating disorder and obesity, according to study results.
